Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Relief Therapeutics Holding AG    RLF   CH0100191136

RELIEF THERAPEUTICS HOLDING AG

(RLF)
  Report
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société RELIEF THERAPEUTICS HOLDING AG
01/11RELIEF, NEURORX AND QUANTUM LEAP ANN : aviptadil) in the I-SPY COVID-19 Trial
PU
01/11NEURORX, RELIEF, AND QUANTUM LEAP AN : aviptadil) in the I-SPY COVID-19 Trial
PR
2020RELIEF THERAPEUTICS : and NeuroRx Conclude Enrollment in their Phase 2b/3 Trial ..
PU
2020NEURORX : and Relief Conclude Enrollment in their Phase 2b/3 Trial of RLF-100&tr..
PR
2020RELIEF THERAPEUTICS : Appoints Chris L.J.J. Stijnen as Chief Commercial Officer
PU
2020RELIEF THERAPEUTICS : Announces Results of Extraordinary General Meeting of THER..
PU
2020RELIEF THERAPEUTICS : Announces Results of Extraordinary General Meeting of THER..
EQ
2020RELIEF THERAPEUTICS : and NeuroRx Meet 165 Patient Enrollment Target in Phase 2b..
PU
2020CORRECTION : NeuroRx and Relief announce initial successful results from expande..
PU
2020CORRECTION : NeuroRx and Relief announce initial successful results from expande..
EQ
2020NEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients
PR
2020NEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients
PU
2020NEURORX AND RELIEF ANNOUNCE INITIAL : 72% survival seen in ICU patients
EQ
2020RELIEF THERAPEUTICS : Announces Notice of Extraordinary General Meeting of THERA..
PU
2020RELIEF THERAPEUTICS : Announces Notice of Extraordinary General Meeting of THERA..
EQ
2020RELIEF THERAPEUTICS : Selects CRO and CDMO for RLF-100TM in Europe
PU
2020RELIEF THERAPEUTICS : Selects CRO and CDMO for RLF-100TM in Europe
EQ
2020NEURORX : and Relief Therapeutics announce enrollment of 150 patients in phase 2..
PR
2020RELIEF THERAPEUTICS : with Partner NeuroRx, Announces Enrollment of 150 Patients..
PU
2020RELIEF THERAPEUTICS : with Partner NeuroRx, Announces Enrollment of 150 Patients..
EQ
2020RELIEF THERAPEUTICS AND NEURORX ANNO : Trial is on track to complete enrollment ..
PU
2020NEURORX AND RELIEF THERAPEUTICS ANNO : Trial is on track to complete enrollment ..
PR
2020RELIEF THERAPEUTICS AND NEURORX ANNO : Trial is on track to complete enrollment ..
EQ
2020RELIEF THERAPEUTICS : Appoints J. Paul Waymack, M.D., Sc.D. as Consultant to Str..
PU
2020RELIEF THERAPEUTICS : Appoints J. Paul Waymack, M.D., Sc.D. as Consultant to Str..
EQ
2020RELIEF THERAPEUTICS : NeuroRx and Relief announce topline efficacy data from pat..
PU
2020NEURORX : and Relief announce topline efficacy data from patients treated with R..
PR
2020RELIEF THERAPEUTICS : NeuroRx and Relief announce topline efficacy data from pat..
EQ
2020RELIEF THERAPEUTICS : Appoints Industry Veteran, Jack Weinstein, as Chief Financ..
EQ
2020RELIEF THERAPEUTICS : NeuroRx and Relief Therapeutics Establish Supply and Distr..
EQ
2020RELIEF THERAPEUTICS : Announces Capital Increase from its Final Tranche of the S..
PU
2020RELIEF THERAPEUTICS : Announces Capital Increase from its Final Tranche of the S..
EQ
2020RELIEF THERAPEUTICS : partner NeuroRx submits request for Emergency Use Authoriz..
PU
2020RELIEF THERAPEUTICS : partner NeuroRx submits request for Emergency Use Authoriz..
EQ
2020NEURORX : submits request for Emergency Use Authorization for RLF-100™ (av..
PR
2020RELIEF THERAPEUTICS : and NeuroRx Announce Partnership for Global Commercializat..
PU
2020RELIEF THERAPEUTICS : and NeuroRx Announce Partnership for Global Commercializat..
PR
2020RELIEF THERAPEUTICS : and NeuroRx Announce Partnership for Global Commercializat..
EQ
2020RELIEF THERAPEUTICS : Condensed consolidated interim financial statements for th..
PU
2020RELIEF THERAPEUTICS : Reports Half-Year 2020 Results
PU
2020RELIEF THERAPEUTICS : Reports Half-Year 2020 Results
EQ
2020RELIEF THERAPEUTICS : Appoints Gilles Della Corte, M.D. as Chief Medical Officer
PU
2020RELIEF THERAPEUTICS : Appoints Gilles Della Corte, M.D. as Chief Medical Officer
EQ
2020RELIEF THERAPEUTICS : Announces Successful Up-listing from OTC Pink to OTCQB and..
PU
2020RELIEF THERAPEUTICS : Announces Successful Up-listing from OTC Pink to OTCQB and..
EQ
2020RELIEF THERAPEUTICS : FDA grants inhaled use IND for RLF-100 (aviptadil) to trea..
PR
2020RELIEF THERAPEUTICS : RLF-100 (aviptadil) clinical trial showed rapid recovery f..
BU
2020RELIEF THERAPEUTICS : RLF-100 (aviptadil) clinical trial showed rapid recovery f..
PR
2020RELIEF THERAPEUTICS : FDA grants Expanded Access Protocol to RLF-100 (Aviptadil)..
BU
2020FDA GRANTS EXPANDED ACCESS PROTOCOL : Currently in development by NeuroRx and R..
PR
2020RELIEF THERAPEUTICS :  NeuroRx and Relief Therapeutics Announce Data Monitoring ..
BU
2020RELIEF THERAPEUTICS : and NeuroRx Announce Enrollment of First Patients with RLF..
BU
2020Relief Therapeutics Announces Filing of IND for Phase 2/3 Clinical Trial of I..
GL
2020RELIEF THERAPEUTICS HOLDING (RLF : SIX) Drug Aviptadil Enters FDA Trial at NYU L..
BU
2020RELIEF THERAPEUTICS (RLF : SIX) Drug Aviptadil Enters FDA Trial at Thomas Jeffer..
BU
2020RELIEF THERAPEUTICS (RLF : SIX) Drug Aviptadil Enters FDA Trial at University of..
BU
2020RELIEF THERAPEUTICS HOLDING SA : Announces the Closing of its Share Exchange Agr..
BU
2020RELIEF THERAPEUTICS : and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVI..
PR
2020RELIEF THERAPEUTICS HOLDING SA (SIX : RLF) Announces Plans to Test Aviptadil for..
BU
2020RELIEF THERAPEUTICS HOLDING SA (SIX : RLF) announces the proposal of Prof. Jonat..
BU
2019RELIEF THERAPEUTICS : Condensed consolidated interim financial statements for th..
PU
2019RELIEF THERAPEUTICS HOLDING SA : Announces Divestment of its Subsidiary Relief T..
BU
2019RELIEF THERAPEUTICS : announces termination of the agreements with Genclis and H..
PU
2019RELIEF THERAPEUTICS HOLDING AG (SIX : RLF) announces today the results of its An..
PU
2019RELIEF THERAPEUTICS : announces an increase of its capital consecutive to a draw..
PU
2018RELIEF THERAPEUTICS : announces signature of service agreement with Genclis SA
PU
2018RELIEF THERAPEUTICS : announces today its financial results for the half-year en..
PU
2018RELIEF THERAPEUTICS : announces significant difference in its 2018 half year fin..
PU
2018RELIEF THERAPEUTICS : announces the prolongation and raise of the amount from th..
PU
2018RELIEF THERAPEUTICS : Holding SA Announces an Out-Licensing Agreement with H&H G..
BU
2018RELIEF THERAPEUTICS HOLDING AG (SIX : RLF) announces the prolongation of its Sha..
PU
2018RELIEF THERAPEUTICS HOLDING AG (SIX : RLF) announces today the results of its An..
PU
2018RELIEF THERAPEUTICS HOLDING AG (SIX : RLF) publishes the agenda for its 2018 Ann..
PU
2018RELIEF THERAPEUTICS : announces today its financial results for the year ended 2..
PU
2018RELIEF THERAPEUTICS : announces today significant difference in its financial re..
PU
1  2  3Next